Other Transaction Agreement 140D042590021
Award Date
9/10/25
Potential Completion Date
9/9/30
Potential Value
$39M
Funding Federal Agency
National Institutes of Health
Contracting Federal Agency
Interior Business Center
Awardee
Safetraces, Inc.
Ultimate Awardee
Not listed
NAICS Category
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed
Major Defense Program
Not listed
Pricing Type
Other
Place of Performance
Pleasanton, CA 94588, USA
Solicitation Procedures
Broad Agency Announcement
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of the Air Force Materiel Command Research Laboratory awarded a $74,437 firm fixed price purchase order to Safetraces Inc. under the Small Business Innovation Research Program Phase I solicitation. This contract will support the development of safe aerosol simulants to verify removal of toxic particles in United States Air Force facilities, with work to be completed by August 3, 2023 at Safetraces's facility in Pleasanton, California. As a total small business set-aside, this SBIR...
This is a $4,923,374.00 Cost Plus Fixed Fee definitive contract awarded by the Department of the Army Materiel Command Research Development and Engineering Command to the non-profit Research Triangle Institute (RTI) International. The contract is for an "IMPROVED AEROSOL SYSTEM TEST" with a completion date of October 31, 2023. RTI has a diverse portfolio of federal prime and subcontract work across agencies like the EPA, HHS, DOJ, and USAID, providing research, technical assistance,...
This is a $749,999.00 firm fixed-price definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency, to Capture Bioscience Inc. for research and development of beads using time-of-flight isotope-based technology to enable highly scalable multiplex serology. The contract supports Area of Interest #23 (Host-Based Diagnostics) and has a period of performance through November 30, 2025. The contract does not have a set-aside designation.
This is a $37,000.00 firm fixed price purchase order contract awarded by the National Center for Advancing Translational Sciences, part of the U.S. Department of Health and Human Services, to Southern Research Institute, a non-profit research organization, for compound testing and cytotoxicity screening related to SARS-CoV-2. The contract does not have a set-aside designation. Through past federal contracts and grants, Southern Research has provided a range of research and development services...
This is a $14,570.72 firm fixed-price purchase order contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to TSI Incorporated, a for-profit manufacturer of precision measurement instruments. The contract is for the delivery of products and services related to aerosol science and air quality monitoring, including aerodynamic particle sizers, scanning mobility particle sizers, optical particle sizers, condensation particle counters, aerosol...
This is a $199,318.00 Other Transaction Agreement (OTA) contract awarded to Enterprise Sensor Systems LLC, a Veteran Owned Limited Liability Company, by the Science and Technology Directorate (S&T) of the U.S. Department of Homeland Security. The contract is for the COVID-19 2020 COVID FINDER NOW ENSENSYS PROTECT (ESS PROTECT)/PHASE 4 PROJECT, which does not have a set-aside designation. The contract has an ultimate completion date of April 30, 2025. As an OTA, the contract utilizes a...
This is a federal contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to Pattern Bioscience, Inc., a biotechnology company, to develop a rapid pathogen identification and antimicrobial susceptibility testing platform. The contract, valued at $40,937,536.73, is for the verification, clinical evaluation, and U.S. Food and Drug Administration (FDA) clearance of this culture-free, phenotypic diagnostic platform. The contract is a...
This is a $2,999,954.00 Firm Fixed Price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Akonni Biosystems Inc., a small business. The contract's purpose is to produce an inexpensive and easy-to-use sputum processing system for on-site molecular testing or transport to a centralized facility in a low-resource clinical setting. The contractor shall deliver a production-equivalent instrument and consumables compliant with CGMP and ISO...
<p>This is a $747,499.00 firm fixed price definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian federal agency, to Bugseq Inc., a for-profit foreign-owned company, to provide development and clinical validation from metagenomics data using AI and machine learning techniques. The contract has an ultimate completion date of July 23, 2025 and was awarded on June 21, 2024. The contract does not have a set-aside designation.</p>
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a $245,000.00 firm fixed-price purchase order to Redshift Bioanalytics Inc., a for-profit manufacturer, for the AQS3 MMS System and accompanying components. The contract has a completion date of September 21, 2023 and was awarded on September 22, 2022. No set-aside was used for this award. The place of performance is Burlington, MA 01803, USA.